EXHIBIT 12. STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS FROM CONTINUING OPERATIONS TO FIXED CHARGES
Eli Lilly and Company and Subsidiaries
(Dollars in millions)
| Years Ended December 31, | ||||||||||||||||||||
| 2002 | 2001 | 2000 | 1999 | 1998 | ||||||||||||||||
| Consolidated pretax income from continuing operations before extraordinary item | $ | 3,457.7 | $ | 3,552.1 | $ | 3,858.7 | $ | 3,245.4 | $ | 2,665.0 | ||||||||||
| Interest from continuing operations and other fixed charges | 140.0 | 208.1 | 225.4 | 213.1 | 198.3 | |||||||||||||||
| Less interest capitalized during the period from continuing operations | (60.3 | ) | (61.5 | ) | (43.1 | ) | (29.3 | ) | (17.0 | ) | ||||||||||
| Earnings | $ | 3,537.4 | $ | 3,698.7 | $ | 4,041.0 | $ | 3,429.2 | $ | 2,846.3 | ||||||||||
Fixed charges1 | $ | 140.0 | $ | 208.1 | $ | 225.4 | $ | 213.2 | $ | 200.5 | ||||||||||
| Ratio of earnings to fixed charges | 25.3 | 17.8 | 17.9 | 16.1 | 14.2 | |||||||||||||||
| 1 Fixed charges include interest from continuing operations for all years presented and preferred stock dividends for 1998 and 1999. |
